Appropriateness of Carpal Tunnel Syndrome Management Compared With

Status Not yet recruiting

Clinical Trial Summary

Purpose: Carpal tunnel syndrome (CTS) is a common peripheral nerve entrapment disorder among adults that causes upper-extremity disability. The American Academy of Orthopedic Surgeons (AAOS) developed an evidence-based appropriate use criteria (AUC) for the management of CTS. This study aims to assess the appropriateness of our practice and the usability of the AUC by comparing the actual management provided at our institution with that recommended by the AUC. Methods: A retrospective review of the electronic medical records at our hospital will be performed between 1 Jan 2016 and 31 Dec 2019. Data will be collected by two authors independently. The collected data will be input into the AUC application to determine the rate of the appropriateness of the treatments. Afterwards, the agreement between the actual treatment provided and the AUC recommendation will be assessed. The primary outcome will be the appropriateness rate. Descriptive statistics such as the mean, range and percentage will be used to summarize the patients' demographics and treatment options. Results: The appropriateness rating (appropriate, maybe, or rarely appropriate) for each treatment will be described with percentages. Similarly, the agreement of the treatments implemented at our institution with the AUC recommendations will be expressed as a proportion. A subgroup analysis within the same cohort compared the appropriateness rates of surgical release of patients across different surgical specialties using chi2 test. Conclusion: This study will show if the management provided at our institution were appropriate and in agreement with the AUC recommendations. Additionally, it will test the usability of AUC for carpal tunnel syndrome as a valuable and practical tool that can be applied in clinical settings.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05275816
Study type	Observational
Source	Hamad Medical Corporation
Contact	Loay Salman, MBBS, MSc
Phone	0097470000262
Email	LSalman2@hamad.qa
Status	Not yet recruiting
Phase
Start date	March 2022
Completion date	August 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05067205` - Minimal Invasive Carpal Tunnel Release With the Novel Device	N/A
Completed	`NCT03184688` - Platelet Rich Plasma for Carpal Tunnel Syndrome	N/A
Completed	`NCT03582735` - Preoperative Neuromobilization Exercises for Individuals With Carpal Tunnel Syndrome	N/A
Completed	`NCT05490420` - Effects of Upper Extremity Manual Lymphatic Drainage on Symptom Severity, Hand Functions, Electrophysiological and Ultrasonographic Measurements in Carpal Tunnel Syndrome	N/A
Recruiting	`NCT05970692` - Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of Atroshi-Lyrén 6-item Symptoms Scale
Completed	`NCT04043780` - Clinical Validation of a Decompression Prototype Splint for Patients With Carpal Tunel Syndrome	N/A
Completed	`NCT03880812` - Cost Information on Carpal Tunnel Syndrome Treatment Decisions	N/A
Recruiting	`NCT05328180` - aDjunct bicarbonatE in Local anaesthesIa for CarpAl Tunnel rElease (DELICATE)	N/A
Recruiting	`NCT05372393` - Carpal Tunnel Release Under Local Anaesthesia With or Without Distal Median Nerve Block	N/A
Recruiting	`NCT05503719` - An Absorbable Suture Versus a Non-absorbable Suture in Carpal Tunnel Release, a Randomized Controlled Trial	N/A
Recruiting	`NCT05466162` - Soft Tissue Massage Along With Mobilization Technique on Symptoms and Functional Status of Carpal Tunnel Syndrome	N/A
Completed	`NCT04060875` - Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
Not yet recruiting	`NCT06294821` - 4AP to Delay Carpal Tunnel Release (CTR)	Phase 2/Phase 3
Not yet recruiting	`NCT04328805` - Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome.	Phase 4
Terminated	`NCT02791529` - Scalpel Versus Electrocautery for Surgical Skin Incision in Open Carpal Tunnel Release	Phase 1
Completed	`NCT02141035` - Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome	Phase 2/Phase 3
Completed	`NCT01887145` - Comparison of Long-term Outcomes Following Endoscopic or Open Surgery for Carpal Tunnel Syndrome	N/A
Recruiting	`NCT01897272` - Post-Operative Splinting After Short-Incision Carpal Tunnel Release: a Prospective Study	N/A
Completed	`NCT01394822` - Neuromuscular Ultrasound for Focal Neuropathies	N/A
Enrolling by invitation	`NCT01017471` - Carpal Tunnel Syndrome Release Using PSU Retractor	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Appropriateness of Carpal Tunnel Syndrome Management Compared With the AAOS Appropriate Use Criteria — CTS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms